Scoring system for optimal cord blood unit selection for single cord blood transplantation

Background: We conducted a retrospective study to categorize the cord blood unit (CBU)s to identify the optimal units. Methods: A total of 8503 adults (female, n = 3592; male, n = 4911) receiving their first single cord blood transplantation (CBT) in 2000-2019 were analyzed. Factors associated with CBUs affecting overall survival (OS) and neutrophil engraftment were selected to create ranked categorization for each outcome, followed by comparison with transplantation using HLA-matched bone marrow (BMT)/peripheral blood stem cell (PBSCT) from unrelated (n = 6052) and related donors (n = 4546). Results: Sex -mismatch, CD34+ cell and CFU-GM counts were selected in the OS analysis. Considering the strong interaction between sex mismatch and CD34+ cell counts, we analyzed females and males separately. For females, female CBU with CD34+ cell counts {greater than or equal to} 0.5 pound 10e5/kg and CFU-GM counts {greater than or equal to} 15 pound 10e3/kg offered the best OS (Group I), followed by other groups with any (Groups II -IV) or all (Group V) of the risk factors. Group I consistently showed favorable OS (Group IV: HR1.22, P = 0.027; Group V: HR1.31, P = 0.047), comparable to those of rBMT/PBSCT (OS: HR1.02, P = 0.654) and uBM/PBSCT in patients with higher rDRI (HR1.07, P = 0.353). Male patients lacked significant factors affecting OS. Categorization for neutrophil engraftment consisting of CD34+ cell and CFU-GM counts, sex mismatch, presence of donor -specific antibodies, and the number of HLA-mismatches was effective but not predicted OS. Conclusion: Our ranked categorizations sufficiently predicted female OS and engraftment. The best -ranked CBUs offered preferable outcomes comparable to conventional BM/PB donors in female but not in male patients. (c) 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.